- ￥3000 - 5600
- Genwaybio
- 美国
- GWB-T00134
- 2025年07月08日
- 详见官方网站
- 详见官方网站
- 详见说明书
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
详见官方网站
- 亚型：
详见官方网站
- 形态：
冻干粉/浓缩液
- 保存条件：
-20℃
- 克隆性：
多克隆
- 标记物：
详见说明书
- 适应物种：
详见说明书
- 宿主：
详见官方网站
- 应用范围：
详见官方网站
- 浓度：
1mg/ml
- 抗体英文名：
Anti- Lipoprotein, Oxidized Low Density CU2+ (CU2+-OX-LDL) Antibody
- 规格：
100ug，200ug，1mg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Oxidized Low-Density Lipoprotein
Oxidized low-density lipoprotein (Ox-LDL) has been studied for over 25 years. Numerous pro- and anti-atherogenic properties have been attributed to Ox-LDL. Yet, Ox-LDL has neither been defined nor characterized, as its components
Antioxidant Activity of Low-Density Lipoprotein
Oxidation of low-density lipoprotein (LDL) is of great interest for epidemiological and clinical diagnostic reasons, as well as for basic scientific research, because it is thought to precede the development of atherosclerotic lesions
Assessment of Susceptibility of Low-Density Lipoprotein to Oxidation
It is now recognized that oxidation of low-density lipoprotein (LDL) is a key event in the development of atherosclerosis (1 ). In vivo, oxidation is believed to occur primarily in the arterial wall. In early atherosclerotic lesions
技术资料暂无技术资料 索取技术资料
